Difference between revisions of "Cystatin A"
m |
|||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 23: | Line 21: | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | | + | | Q45 |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| Line 35: | Line 33: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1gd3.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1gd3.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 47: | Line 46: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
| − | [[Category: | + | [[Category:Epidermal transglutaminase|*]] |
Latest revision as of 12:02, 10 March 2015
| Cystatin A | |
|---|---|
| Substrate peptide name | Cystatin A |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cornified envelope |
| Swissprot ID | P01040 |
| Reactive glutamines | Q45 |
| Reactive lysines | Not determined yet |
| Substrate sequence | VQYKTQVVAGT |
| Structure | 1GD3 |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:1353732 |
| Notes | |
